Hemispherx Biopharma Inc (NYSE American:HEB)

0.3207
Delayed Data
As of Jun 22
 +0.0011 / +0.34%
Today’s Change
0.28
Today|||52-Week Range
0.74
-7.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues197.0K133.0K92.0K437.0K
 
 
 
 
 
Cost of Goods Sold555.0K623.0K1.1M179.0K
 
 
 
 
 
Depreciation And Amortization696.0K975.0K1.2M1.0M
 
 
 
 
 
 
Operating ExpensesGross Income-1.1M-1.5M-2.2M-746.0K
 
 
 
 
 
General Expenses17.6M15.0M11.5M10.7M
 
 
 
 
 
Research And Development8.5M7.8M5.0M4.1M
 
 
 
 
 
Total Operating Expenses18.9M16.6M13.8M11.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.7M-16.4M-13.7M-11.4M
 
 
 
 
 
Extraordinary Credit14.0K0.003.3M2.4M
 
 
 
 
Extraordinary Charge-145.0K-315.0K-134.0K-7.0K
 
 
 
 
 
Interest Expense On Debt11.0K3.0K0.00139.0K
 
 
 
 
Other Expenses680.0K1.2M2.9M791.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.5M-15.2M-7.5M-8.3M
 
 
 
 
 
Net Income-17.5M-15.2M-7.5M-8.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.7M19.7M21.8M28.7M
 
 
 
 
 
Shares To Calculate EPS Diluted15.7M19.7M21.8M28.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.08-$0.72-$0.34-$0.29
 
 
 
 
 
EPS Diluted-$1.08-$0.72-$0.34-$0.29